|
|
|
1 Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan; 2 Department of Human Pathology and Departmen of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan; 3 Second Department of Surgery, Gunma University School of Medicine, Maebashi, Gunma 371-0034, Japan
Cadherins mediate Ca2+-dependent cell–cell adhesion. Efficient export of cadherins from the endoplasmic reticulum (ER) is known to require complex formation with β-catenin. However, the molecular mechanisms underlying this requirement remain elusive. Here we show that PX-RICS, a β-catenin-interacting GTPase-activating protein (GAP) for Cdc42, mediates ER-to-Golgi transport of the N-cadherin/β-catenin complex. Knockdown of PX-RICS expression induced the accumulation of the N-cadherin/β-catenin complex in the ER and ER exit site, resulting in a decrease in cell–cell adhesion. PX-RICS was also required for ER-to-Golgi transport of the fibroblast growth factor-receptor 4 (FGFR4) associated with N-cadherin. PX-RICS-mediated ER-to-Golgi transport was dependent on its interaction with β-catenin, phosphatidylinositol-4-phosphate (PI4P), Cdc42, and its novel binding partner
-aminobutyric acid type A receptor-associated protein (GABARAP). These results suggest that PX-RICS ensures the efficient entry of the N-cadherin/β-catenin complex into the secretory pathway, and thereby regulates the amount of N-cadherin available for cell adhesion and FGFR4-mediated signaling.
[Keywords: N-cadherin; β-catenin; PX-RICS; GABARAP; PI4P; Cdc42]]
Received November 7, 2007; revised version accepted March 4, 2008.
E-MAIL nakamura{at}iam.u-tokyo.ac.jp; FAX 81-3-5841-8482.
5 E-MAIL akiyama{at}iam.u-tokyo.ac.jp; FAX 81-3-5841-8482.
Supplemental material is available at http://www.genesdev.org.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1632308.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?